NCT05987319招募中不适用
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- % of subjects satisfied with treatments.
研究概览
简要总结
The goal of the Potenza device used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
详细描述
Up to 12 subjects will be enrolled at 1 study center. Subjects will be enrolled into 2 groups. Group A will receive treatments on the face, neck, and/or body. Group B will receive split-face treatments where each side of the face may be treated with different tips. Subjects will attend a screening/pretreatment visit which may be performed on the same day as the treatment visit. Subjects may receive up to 5 treatments.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 22 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A healthy, non-smoking male or female between the age of 22-65 years old.
- •Fitzpatrick skin type I to VI.
- •Understands and accepts obligation not to receive any other procedures on the treatment area through the length of the study.
- •Understands and accepts the obligation and is logistically able to be present for all visits.
- •Is willing to comply with all requirements of the study and sign the informed consent document.
排除标准
- •Is pregnant or of childbearing potential and not using medically effective birth control, or has been pregnant in the last 3 months, currently breast feeding or planning a pregnancy during the study.
- •The subject is currently enrolled in an investigational drug or device trial or has received an investigational drug or been treated with an investigational device within in the area to be treated 1 month prior to entering this study.
- •The subject has a pacemaker.
- •The subject had previous use of gold thread skin rejuvenation.
- •The subject has a cut, wound, or infected skin on the area to be treated (but skin eruptions may be treated).
- •The subject has a metal implant that interferes with the transmission of energy to the electrical field.
- •The subject has any embedded electronic devices that give or receive a signal.
- •The subject has Implantable Cardiac Defibrillators (ICD) or Cardiac Resynchronization Therapy (CRT) devices: treatment may interfere with the functionality of the device and/or damage the electronic implant.
- •The subject is allergic to adhesives such as glues on medical tape: they should be alerted that a rash may occur on the neutral electronic monitoring pad (NEM or neutral pad) site, and an over-the-counter preparation may be used to treat the area.
- •The subject is allergic to gold.
- •The subject has an unrealistic expectation of the results: this is not plastic surgery, and all subjects should be fully informed of the treatment's expected results.
- •The subject has nerve insensitivity to heat in the treatment area or in the neutral pad placement area.
- •The subject has severe laxity or sagging that causes redundant folds of tissue or hanging skin in the area to be treated: this treatment will be ineffective.
- •The subject has used Accutane (isotretinoin) six to twelve months prior to treatment, as this can thin the skin and make it brittle.
- •The subject is taking aspirin or are currently taking antiplatelets, thrombolytics, anti- inflammatories or anticoagulants.
- •The subject has a history of bleeding coagulopathies.
- •The subject is allergic to topical anesthetic.
- •The subject has any of the following conditions:
- •Autoimmune disease
- •Herpes simplex
- •Hypertension
- •Dermatitis
- •The subject has keloid formation propensity.
- •Subjects with electronic implants such as cardiac defibrillator. It may interfere with operation of electronic implants or damage the implants, causing risks.
- •The subject has any condition or is in a situation which in the investigator's opinion may put the subject at significant risk, may confound study results or may interfere.
- •significantly with the subject's participation.
结局指标
主要结局
% of subjects satisfied with treatments.
时间窗: 30 days post last treatment
% of subjects satisfied with the treatment will the reported at the 30 days follow up.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling DeviceWrinklesFine LinesCrepey SkinAcne ScarsActive AcneEnlarged PoresLoose SkinNCT05254210Cynosure, Inc.10
已完成
不适用
Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic AcidSkin FoldsWrinkleNCT05450380Mesoestetic Pharma Group S.L.50
已完成
不适用
Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping StudiesVentricular TachycardiaAtrial FlutterNCT01139814Catheter Robotics, Inc.181
已完成
不适用
Feasibility Study of the Magnetic Anal Sphincter (FENIX System)Fecal IncontinenceNCT01625221Torax Medical Incorporated35
已完成
不适用
Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous LesionsMalignant MelanomaNCT05172232Linkoeping University231